STIM1 and breast carcinoma: These data indicate that the observed enhancement of Tam-induced IGFBP-1 in breast cancer cells cultured in 0 mM D-glucose is dependent on GPER1 and suggest that breast cancer cells exposed to high levels of D-glucose may be less sensitive to some mechanisms of tamoxifen action due to decreased GPER1 expression.